{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:02:30Z","timestamp":1790438550450,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,9,27]],"date-time":"2009-09-27T00:00:00Z","timestamp":1254009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/nchembio.221","type":"journal-article","created":{"date-parts":[[2009,9,27]],"date-time":"2009-09-27T18:14:55Z","timestamp":1254075295000},"page":"849-856","source":"Crossref","is-referenced-by-count":116,"title":["Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting"],"prefix":"10.1038","volume":"5","author":[{"given":"Ranjana","family":"Pathania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumaya","family":"Zlitni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Gerritsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Awuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Melacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred A","family":"Capretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,27]]},"reference":[{"key":"BFnchembio221_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/1568005014606099","volume":"1","author":"CW Ford","year":"2001","unstructured":"Ford, C.W., Zurenko, G.E. & Barbachyn, M.R. The discovery of linezolid, the first oxazolidinone antibacterial agent. Curr. Drug Targets Infect. Disord. 1, 181\u2013199 (2001).","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"BFnchembio221_CR2","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1517\/14656566.5.11.2321","volume":"5","author":"KL LaPlante","year":"2004","unstructured":"LaPlante, K.L. & Rybak, M.J. Daptomycin - a novel antibiotic against Gram-positive pathogens. Expert Opin. Pharmacother. 5, 2321\u20132331 (2004).","journal-title":"Expert Opin. Pharmacother."},{"key":"BFnchembio221_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1021\/cr030116o","volume":"105","author":"ED Brown","year":"2005","unstructured":"Brown, E.D. & Wright, G.D. New targets and screening approaches in antimicrobial drug discovery. Chem. Rev. 105, 759\u2013774 (2005).","journal-title":"Chem. Rev."},{"key":"BFnchembio221_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne, D.J., Gwynn, M.N., Holmes, D.J. & Pompliano, D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29\u201340 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnchembio221_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nature04784","volume":"441","author":"J Wang","year":"2006","unstructured":"Wang, J. et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441, 358\u2013361 (2006).","journal-title":"Nature"},{"key":"BFnchembio221_CR6","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1371\/journal.ppat.0030092","volume":"3","author":"D Xu","year":"2007","unstructured":"Xu, D. et al. Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathog. 3, e92 (2007).","journal-title":"PLoS Pathog."},{"key":"BFnchembio221_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/6791","volume":"21","author":"G Giaever","year":"1999","unstructured":"Giaever, G. et al. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 21, 278\u2013283 (1999).","journal-title":"Nat. Genet."},{"key":"BFnchembio221_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0092-8674(03)01035-3","volume":"116","author":"PY Lum","year":"2004","unstructured":"Lum, P.Y. et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116, 121\u2013137 (2004).","journal-title":"Cell"},{"key":"BFnchembio221_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nbt919","volume":"22","author":"AB Parsons","year":"2004","unstructured":"Parsons, A.B. et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22, 62\u201369 (2004).","journal-title":"Nat. Biotechnol."},{"key":"BFnchembio221_CR10","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1073\/pnas.0307122101","volume":"101","author":"K Baetz","year":"2004","unstructured":"Baetz, K. et al. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. Proc. Natl. Acad. Sci. USA 101, 4525\u20134530 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio221_CR11","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.chembiol.2004.08.014","volume":"11","author":"X Li","year":"2004","unstructured":"Li, X. et al. Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. Chem. Biol. 11, 1423\u20131430 (2004).","journal-title":"Chem. Biol."},{"key":"BFnchembio221_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1365-2958.2000.01926.x","volume":"37","author":"HI Zgurskaya","year":"2000","unstructured":"Zgurskaya, H.I. & Nikaido, H. Multidrug resistance mechanisms: drug efflux across two membranes. Mol. Microbiol. 37, 219\u2013225 (2000).","journal-title":"Mol. Microbiol."},{"key":"BFnchembio221_CR13","doi-asserted-by":"publisher","first-page":"IN1","DOI":"10.1016\/j.bbamcr.2004.07.002","volume":"1694","author":"H Tokuda","year":"2004","unstructured":"Tokuda, H. & Matsuyama, S. Sorting of lipoproteins to the outer membrane in E. coli. Biochim. Biophys. Acta 1694, IN1\u2013IN9 (2004).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio221_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0022-2836(80)90283-1","volume":"138","author":"MJ Casadaban","year":"1980","unstructured":"Casadaban, M.J. & Cohen, S.N. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J. Mol. Biol. 138, 179\u2013207 (1980).","journal-title":"J. Mol. Biol."},{"key":"BFnchembio221_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/dnares\/dsi012","volume":"12","author":"M Kitagawa","year":"2005","unstructured":"Kitagawa, M. et al. Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research. DNA Res. 12, 291\u2013299 (2005).","journal-title":"DNA Res."},{"key":"BFnchembio221_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-7258(02)00222-X","volume":"95","author":"AF Chalker","year":"2002","unstructured":"Chalker, A.F. & Lunsford, R.D. Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach. Pharmacol. Ther. 95, 1\u201320 (2002).","journal-title":"Pharmacol. Ther."},{"key":"BFnchembio221_CR17","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1128\/jb.177.14.4194-4197.1995","volume":"177","author":"ED Brown","year":"1995","unstructured":"Brown, E.D., Vivas, E.I., Walsh, C.T. & Kolter, R. MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli. J. Bacteriol. 177, 4194\u20134197 (1995).","journal-title":"J. Bacteriol."},{"key":"BFnchembio221_CR18","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1016\/S0040-4039(98)01755-9","volume":"39","author":"T Kuzuyama","year":"1998","unstructured":"Kuzuyama, T., Shimizu, T., Takahashi, S. & Seto, H. Fosmidomycin, a specific inhibitor of 1-dexoy-D-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis. Tetrahedr. Lett. 39, 7913\u20137916 (1998).","journal-title":"Tetrahedr. Lett."},{"key":"BFnchembio221_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0378-1119(80)90003-7","volume":"8","author":"JI Rood","year":"1980","unstructured":"Rood, J.I., Laird, A.J. & Williams, J.W. Cloning of the Escherichia coli K-12 dihydrofolate reductase gene following mu-mediated transposition. Gene 8, 255\u2013265 (1980).","journal-title":"Gene"},{"key":"BFnchembio221_CR20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/9780470122723.ch9","volume":"27","author":"GH Hitchings","year":"1965","unstructured":"Hitchings, G.H. & Burchall, J.J. Inhibition of folate biosynthesis and function as a basis for chemotherapy. Adv. Enzymol. Relat. Areas Mol. Biol. 27, 417\u2013468 (1965).","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"BFnchembio221_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1021\/bi00892a001","volume":"3","author":"FC Neuhaus","year":"1964","unstructured":"Neuhaus, F.C. & Lynch, J.L. The enzymatic synthesis of D-alanyl-D-alanine. 3. On the inhibition of D-alanyl-D-alanine synthetase by the antibiotic D-cycloserine. Biochemistry 3, 471\u2013480 (1964).","journal-title":"Biochemistry"},{"key":"BFnchembio221_CR22","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1128\/JB.110.3.978-987.1972","volume":"110","author":"MP Lambert","year":"1972","unstructured":"Lambert, M.P. & Neuhaus, F.C. Mechanism of D-cycloserine action: alanine racemase from Escherichia coli W. J. Bacteriol. 110, 978\u2013987 (1972).","journal-title":"J. Bacteriol."},{"key":"BFnchembio221_CR23","doi-asserted-by":"publisher","first-page":"2006.0008","DOI":"10.1038\/msb4100050","volume":"2","author":"T Baba","year":"2006","unstructured":"Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2, 2006.0008 (2006).","journal-title":"Mol. Syst. Biol."},{"key":"BFnchembio221_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev.biochem.73.011303.074104","volume":"73","author":"V Koronakis","year":"2004","unstructured":"Koronakis, V., Eswaran, J. & Hughes, C. Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu. Rev. Biochem. 73, 467\u2013489 (2004).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnchembio221_CR25","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q","volume":"38","author":"M Mayer","year":"1999","unstructured":"Mayer, M. & Meyer, B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. 38, 1784\u20131788 (1999).","journal-title":"Angew. Chem. Int. Ed."},{"key":"BFnchembio221_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1023\/A:1013302231549","volume":"21","author":"C Dalvit","year":"2001","unstructured":"Dalvit, C., Fogliatto, G., Stewart, A., Veronesi, M. & Stockman, B. WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability. J. Biomol. NMR 21, 349\u2013359 (2001).","journal-title":"J. Biomol. NMR"},{"key":"BFnchembio221_CR27","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1128\/JB.184.23.6490-6499.2002","volume":"184","author":"CA Elkins","year":"2002","unstructured":"Elkins, C.A. & Nikaido, H. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J. Bacteriol. 184, 6490\u20136498 (2002).","journal-title":"J. Bacteriol."},{"key":"BFnchembio221_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0014-5793(98)01334-9","volume":"439","author":"T Tajima","year":"1998","unstructured":"Tajima, T., Yokota, N., Matsuyama, S. & Tokuda, H. Genetic analyses of the in vivo function of LolA, a periplasmic chaperone involved in the outer membrane localization of Escherichia coli lipoproteins. FEBS Lett. 439, 51\u201354 (1998).","journal-title":"FEBS Lett."},{"key":"BFnchembio221_CR29","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.bcp.2005.09.018","volume":"71","author":"LB Rice","year":"2006","unstructured":"Rice, L.B. Unmet medical needs in antibacterial therapy. Biochem. Pharmacol. 71, 991\u2013995 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"BFnchembio221_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/j.1460-2075.1993.tb05652.x","volume":"12","author":"S Matsuyama","year":"1993","unstructured":"Matsuyama, S., Fujita, Y. & Mizushima, S. SecD is involved in the release of translocated secretory proteins from the cytoplasmic membrane of Escherichia coli. EMBO J. 12, 265\u2013270 (1993).","journal-title":"EMBO J."},{"key":"BFnchembio221_CR31","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1002\/j.1460-2075.1995.tb07342.x","volume":"14","author":"S Matsuyama","year":"1995","unstructured":"Matsuyama, S., Tajima, T. & Tokuda, H. A novel periplasmic carrier protein involved in the sorting and transport of Escherichia coli lipoproteins destined for the outer membrane. EMBO J. 14, 3365\u20133372 (1995).","journal-title":"EMBO J."},{"key":"BFnchembio221_CR32","first-page":"149","volume":"44","author":"B Meyer","year":"2004","unstructured":"Meyer, B. et al. Saturation transfer difference NMR spectroscopy for identifying ligand epitopes and binding specificities. Ernst Schering Res. Found. Workshop 44, 149\u2013167 (2004).","journal-title":"Ernst Schering Res. Found. Workshop"},{"key":"BFnchembio221_CR33","unstructured":"National Committee on Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically (National Committee on Clinical Laboratory Standards, Wayne, Pennsylvania, USA, 2000)."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchembio.221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.221","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T19:57:23Z","timestamp":1710619043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,27]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BFnchembio221"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.221","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,27]]}}}